Clinical Characteristics of The First IMLYGIC™ Patients With Unresectable Stage IIIB-IVM1a Melanoma Treated in Routine Clinical Practice, in Selected European Countries (20140413)

26/01/2017
22/02/2024
EU PAS number:
EUPAS17410
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01.02.05 Special Protocol Ver 1.0 2016-10-28 English

English (451.13 KB - PDF) View document
Updated protocol

20140413 01.02.06 Public Redacted Protocol Ver 1.0 English

First published: 22/02/2024
English (227.41 KB - PDF) View document
Study results
Study results

20140413 Observational Research Study Report Abstract

English (194.6 KB - PDF) View document
Study report
Other information